Will this mean that UHC will accept and pay for all future Calmare treatment cases associated with CRPS, or will they proceed on a case-by-case basis?
How will the State of California Dept of Insurance now proceed as well?
Under the circumstances, if this is viewed as a decision that approves Calmare for CRPS treatments, why has there not been a much bigger jump in share price (although volume is up more than usual)?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.